Top Photodynamic Therapy Providers (2025)
09 Jul, 2025

The photodynamic therapy (PDT) market is anticipated to grow significantly, reaching US$7.48 billion by 2033, up from US$3.89 billion in 2024. This growth is driven by a compound annual growth rate (CAGR) of 7.52% from 2025 to 2033. The market for photodynamic therapy (PDT) is rising rapidly as a result of growing medical uses and improvements in light-based treatments. PDT offers a less intrusive option to surgery or chemotherapy by targeting and destroying aberrant cells using photosensitizing chemicals that are activated by certain light. It is being utilized more and more to treat eye diseases, skin conditions like actinic keratosis, and malignancies. The accuracy and efficacy of treatments are being enhanced by advancements in photosensitizers and light delivery technologies. To improve results, the integration of the therapy with other treatments is also being investigated. With its robust healthcare infrastructure and high adoption rate, North America dominates the market, while Asia-Pacific is expanding at the quickest rate because of improved access to healthcare and growing awareness. Global demand for PDT is increasing due to its overall effectiveness and low adverse effects.

Discover key trends, growth opportunities, and major challenges shaping the Photodynamic Therapy Industry in Renub Research’s latest in-depth market report. Download your free sample now

List of Leading Companies in the Photodynamic Therapy Market

1. Galderma S.A

Establishment: 1981

Headquarters: Switzerland

Website: www.galderma.com

Revenue: $4.4B in 2023

Galderma SA (Galderma) offers skin health products based on science. The company's operations include the creation and marketing of medical treatments and skincare products. Prescription medications, cosmetics, and consumer skincare products are all part of its product line. Alastin, Cetaphil, Sculptra, Azzalure, and Restylane are some of the company's well-known brands. Galderma offers its solutions to treat a variety of skin health issues, including aging skin rejuvenation and keeping healthy skin. It reaches consumers and a variety of industries through a network of retailers and healthcare providers. The business operates in more than 90 countries, giving it a global reach. The headquarters of Galderma are located in Lausanne, Switzerland's Lake Geneva.

2. Sun Pharmaceutical Industries Ltd

Establishment: 1983

Headquarters: India

Website: sunpharma.com

Revenue: $6.3B in 2024

A variety of pharmaceutical formulations, including both branded and generic medications, are available from Sun Pharmaceutical Industries Ltd. (Sun Pharma), a specialty pharmaceutical company. Products for the treatment of heart conditions, neurological, nephrological, gastroenterological, orthopedic, and ophthalmologic conditions are among the company's offerings. The company manufactures complicated formulations, active pharmaceutical ingredients (APIs), and over-the-counter medications in addition to conducting process chemistry and product development. It provides medications in a range of dose forms, including liquids, ointments, creams, injectables, tablets, capsules, and inhalers. The headquarters of Sun Pharma are located in Mumbai, Maharashtra, India.

3. Biofrontera Inc.

Establishment: 2015

Headquarters: Germany

Website: www.biofrontera.com

Revenue: $34.9M in 2024

Dermatological product development, research, and distribution are the areas of expertise for Biofrontera AG (Biofrontera), a biopharmaceutical business. The main products of Biofrontera are the topical medication Ameluz, as well as the unique red-light lamps BF-RhodoLED and RhodoLED XL, which are used for photodynamic therapy of specific superficial skin malignancies and their precursors. Additionally, the company sells the Belixos dermocosmetics line, which treats diseased or damaged skin. In addition to using independent license partners in other European nations, the US, and Asian and Oceanic markets, the corporation sells its goods through its own sales teams in Germany, Spain, and the UK. The headquarters of Biofrontera are in Leverkusen, Germany's North Rhine-Westphalia.

4. Lumibird S.A

Establishment: 1970

Headquarters: Lannion, Bretagne

Website: www.lumibird.com

LUMIBIRD is regarded as one of the top experts in laser technology worldwide. The company has been in business for more than 50 years and is an expert in three main technologies: fiber lasers, solid-state lasers, and laser diodes. It creates, produces, and sells high-performance lasers for a variety of uses, such as manufacturing and lidar sensors in industry, scientific research in labs and academic institutions, ophthalmology in medicine, and defense. LUMIBIRD, which was formerly known as the Quantel-Keopsys group, has over 1,000 employees and is listed on the Euronext Stock Exchange. The firm effectively serves a global customer base by running production and research and development sites on several continents and maintaining a strong global sales and support network.

5. Bausch Health Companies Inc.

Establishment: 1959

Headquarters: Canada

Website: www.bauschhealth.com

Revenue: $9.6B in 2023

Pharmaceuticals, over-the-counter (OTC) goods, and medical devices are all produced, developed, and marketed by Bausch Health Companies Inc. (Bausch Health). Dermatology, gastrointestinal, eye health, neurology, aesthetic devices, dentistry, and consumer health are among the therapeutic areas for which the company provides products. It provides a range of branded and generic products. Around the world, Bausch Health maintains facilities for marketing, distribution, warehousing, research, and administration. The corporation sells its goods directly or indirectly throughout the US, Canada, Africa, the Middle East, Australia, Latin America, and Europe, among other places. Among other places, it runs manufacturing plants in the US, Brazil, Columbia, Germany, and Canada. The main office of Bausch Health is located in Laval, Quebec, Canada.

6. Soligenix Inc.

Establishment: 1987

Headquarters: United States of America

Website: www.soligenix.com

Revenue: $ 119,400 in 2023

A late-stage biopharmaceutical business is Soligenix Inc. It is centered on the creation and marketing of goods to treat uncommon illnesses. Its research portfolio includes SGX302 for mild-to-moderate psoriasis, HyBryte for cutaneous T-cell lymphoma, and SGX942 for oral mucositis in head and neck cancer. The business also uses SGX945 to treat pediatric Crohn's disease and aphthous ulcers in Behcet's illness. It is developing ThermoVax, improving the thermostability of vaccines against the Marburg, ebola, and ricin toxin viruses. While SGX943 targets newly developing infectious diseases, the RiVax vaccine attempts to prevent ricin toxin poisoning. The US city of Princeton, New Jersey, is home to Soligenix's headquarters.

7.Theralase Technologies Inc.

Establishment: 1994

Headquarters: Toronto, ON

Website: https://linktr.ee/theralasetechnologiesinc

Theralase Technologies is a clinical-stage pharmaceutical company based in Canada that focuses on the safe and efficient targeting of different types of cancer through the study and development of light-activated photodynamic chemicals and their associated medication formulations. The company was founded in 1994 with the goal of improving the quality of life for cancer patients by concentrating its efforts on the prevention, relief, and treatment of illnesses utilizing cutting-edge medicines.

Production of therapeutic laser technology for commercial usage and research and development of laser-based technologies intended to eradicate cancer cells and other illness conditions comprise Theralase's two primary business areas. In order to commercialize safe and efficient light-activated photodynamic treatments, the firm is committed to finding, creating, and improving anti-cancer remedies.